Clinical Research

Phase I Clinical Trial To Treat Clostridium Difficile Infection Launches

Each year, roughly 250,000 people in the United States require hospital care for Clostridium difficile (C. difficile) infection and at least 14,000 people die from it, according to the U.S. Centers for Disease Control and Prevention (CDC). As a result, th ...

Article - News Staff - Jul 9 2014 - 12:30pm

Minimally Invasive Heart Stents Are Safer

A study has documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms; weaknesses in the body's largest artery that can rupture, causing potentially lethal internal bleeding. ...

Article - News Staff - Jul 9 2014 - 5:00pm

Hyperphosphatemia: Ferric Citrate Long-term Phase 3 Study Results Published

New York, NY- July 24, 2014-- Keryx Biopharmaceuticals, Inc. has published results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric citrate), their investigational oral ferric iron-based phosphate binder for the treatment of ...

Article - News Staff - Jul 27 2014 - 8:07am

Achalasia Esophagus Disease Is Autoimmune

Achalasia is a rare disease, affecting 1 in 100,000 people, characterized by a loss of nerve cells in the esophageal wall and manifested as chest pain during eating, weight loss, and regurgitation of food. When we swallow, a sphincter in the lower esophag ...

Article - News Staff - Jul 29 2014 - 12:01pm

C1 Inhibitor Inhibits Antibody-Mediated Rejection Following Kidney Transplant

Results  presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in highly sensitized patients. C1-INH ...

Article - News Staff - Aug 3 2014 - 9:46am

Xilonix Phase III European Registration Study For Treatment Of Colorectal Cancer

XBiotech has begun its European Phase III study using its novel cancer drug Xilonix™ for the treatment of colorectal cancer. Xilonix is an antiobody works to block a number of processes that tumors use to grow and spread, such as potentially inhibiting the ...

Article - News Staff - Aug 3 2014 - 11:30am

P45 And P75: New Clues To Repairing An Injured Spinal Cord

Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is — while many animals have this ability, humans don't. But new research from the Salk Institute suggests that a small molecule may be ...

Article - News Staff - Aug 5 2014 - 4:02pm

World Of 2015: Cure For Arthritis May Go Into Clinical Trials Next Year

Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body- the joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. It affects 0.5% to 1% of the world's populati ...

Article - News Staff - Aug 6 2014 - 10:50am

Laparoscopic Gallbladde Removal Is Safe For Kids

A recent study conducted by Mayo Clinic researchers recommends laparoscopic cholecystectomies (surgical removal of the gallbladder) for pediatric patients suffering from gallstones and other gallbladder diseases.  A cholecystectomy is a surgical procedure ...

Article - News Staff - Aug 7 2014 - 4:30pm

AE37 Prostate Cancer Vaccine Clinical Trial Results Published

Generex Biotechnology Corporation has announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study demonstrates an association between a specific immune response ge ...

Article - News Staff - Aug 11 2014 - 9:02am